Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(9.9%),Point72 Capital Advisors, Inc.(9.9%)等
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%)等
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(9.3%),Commodore Capital Master LP(9.3%)
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(0%),Averill Master Fund, Ltd.(0%)等
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Kynam Capital Management, LP(8.36%),Kynam Capital Management GP, LLC(8.36%)等
Cogent Biosciences | 10-Q:2024财年三季报
Cogent Biosciences | 8-K:Cogent Biosciences报告近期业务亮点和2024年第三季度财务业绩
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(12.068%),Abigail P. Johnson(12.068%)
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(7.601%),Abigail P. Johnson(7.601%)
Cogent Biosciences | 4:持股变动声明-董事 Ferrante Karen Jean
Cogent Biosciences | 8-K:重大事件
Cogent Biosciences | S-8:员工福利计划证券登记
Cogent Biosciences | 10-Q:2024财年二季报
Cogent Biosciences | 8-K:Cogent Biosciences报告近期业务亮点和2024年第二季度财务业绩
Cogent Biosciences | 4:持股变动声明-董事 Ferrante Karen Jean
Cogent Biosciences | 8-K:重大事件
Cogent Biosciences | 4:持股变动声明-董事 CAIN CHRISTOPHER W.
Cogent Biosciences | 4:持股变动声明-董事 Ros Matthew
Cogent Biosciences | 4:持股变动声明-董事 Ferrante Karen Jean
Cogent Biosciences | 4:持股变动声明-董事 Harwin Peter Evan
暂无数据
暂无数据